Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study
European Journal of Cancer · 2026-09 · 245 · 116943
DOI: 10.1016/j.ejca.2026.116943 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-09. Verfasst von Thijmen H T Broekman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location University of Amsterdam, Department of medical oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam UMC, location University of Amsterdam, Department of medical oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: t.h.t.broekman@amsterdamumc.nl.
- Cancer Center Amsterdam, Amsterdam, the Netherlands; Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
- GROW Research Institute for Oncology & Reproduction, Maastricht UMC+, Maastricht, the Netherlands; Department of Medical Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
- Department of Medical Oncology, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center, St. Antonius Hospital, Nieuwegein, Utrecht, the Netherlands.
- Department of Medical Oncology, Isala Oncology Centre, Zwolle, the Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Zitieren
APA
Broekman, T. H. T., Mackay, T. M., de Vos-Geelen, J., Cirkel, G. A., Graus, M. U. J. E., de Groot, J. B., Homs, M. Y. V., Luelmo, S. A. C., Mekenkamp, L. J. M., Streppel, M. M., Voermans, R. P., Wumkes, M. L., Besselink, M. G., van der Geest, L. G., Wilmink, J. W., & Dutch Pancreatic Cancer Group (2026). Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study. European Journal of Cancer, 245, 116943. https://doi.org/10.1016/j.ejca.2026.116943
Vancouver
Broekman THT, Mackay TM, de Vos-Geelen J, Cirkel GA, Graus MUJE, de Groot JB, et al. Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study. European Journal of Cancer. 2026;245:116943. doi:10.1016/j.ejca.2026.116943
BibTeX
@article{Broekman2026,
author = {Broekman, Thijmen H T and Mackay, Tara M and de Vos-Geelen, Judith and Cirkel, Geert A and Graus, Merlijn U J E and de Groot, Jan-Willem B and Homs, Marjolein Y V and Luelmo, Saskia A C and Mekenkamp, Leonie J M and Streppel, Mirte M and Voermans, Rogier P and Wumkes, Miriam L and Besselink, Marc G and van der Geest, Lydia G and Wilmink, Johanna W and Dutch Pancreatic Cancer Group, Dutch Pancreatic Cancer Group},
title = {Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study},
journal = {European Journal of Cancer},
year = {2026},
volume = {245},
pages = {116943},
doi = {10.1016/j.ejca.2026.116943}
}
EUVIMED